Cargando…
Challenges in Treating Statin-Associated Necrotizing Myopathy
Myalgia and mild elevation in muscle enzymes are common side effects of statin therapy. While these symptoms are generally self-limited, in rare cases, statin use is associated with an immune-mediated necrotizing myopathy caused by development of autoantibodies against HMG-CoA reductase. The primary...
Autores principales: | Webster, Patrick, Wiemer, Nicholas, Al Harash, Abdalhamid, Marshall, Cody, Khatoon, Nazia, Lucke, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929690/ https://www.ncbi.nlm.nih.gov/pubmed/33708450 http://dx.doi.org/10.1155/2021/8810754 |
Ejemplares similares
-
Statin-Induced Necrotizing Autoimmune Myopathy
por: Gawey, Brent, et al.
Publicado: (2020) -
Statin-Induced Autoimmune Necrotizing Myopathy
por: Jayatilaka, Sahani, et al.
Publicado: (2021) -
IgA Vasculitis Nephritis: A Case Series and Comparison of Treatment Guidelines
por: Al Harash, Abdalhamid, et al.
Publicado: (2020) -
When Should a Patient with Statin-Induced Myopathy Be Re-challenged? A Case of Necrotizing Autoimmune Myopathy
por: Obreja, Elena, et al.
Publicado: (2018) -
Statin‐associated necrotizing autoimmune myopathy with concurrent myasthenia gravis
por: Frasson, Emma, et al.
Publicado: (2021)